Edition:
United Kingdom

Guerbet SA (GRBT.PA)

GRBT.PA on Paris Stock Exchange

48.70EUR
13 Sep 2019
Change (% chg)

€0.70 (+1.46%)
Prev Close
€48.00
Open
€47.60
Day's High
€49.35
Day's Low
€47.60
Volume
3,387
Avg. Vol
4,700
52-wk High
€65.50
52-wk Low
€46.00

Latest Key Developments (Source: Significant Developments)

Guerbet Obtains CE Marking For SeQure And DraKon
Wednesday, 24 Apr 2019 

April 24 (Reuters) - GUERBET SA ::OBTAINS CE MARKING FOR MICROCATHETERS SEQURE AND DRAKON IN INTERVENTIONAL IMAGING.  Full Article

Guerbet: Transition From Temporary Importation To Regular Supply For Lipiodol Injection
Monday, 1 Apr 2019 

April 2 (Reuters) - GUERBET SA ::GUERBET LLC USA ANNOUNCED ON MONDAY TRANSITION FROM TEMPORARY IMPORTATION TO REGULAR SUPPLY FOR LIPIODOL (ETHIODIZED OIL) INJECTION; ALSO INTRODUCES NEW GLASS VIAL CONTAINER.IMPORTATION REMAINED IN EFFECT THROUGH FEBRUARY 2019, WHILE GUERBET QUALIFIED NEW FDA REGISTERED MANUFACTURING SITE.NEWLY MANUFACTURED LIPIODOL WILL ADDITIONALLY BE PACKAGED IN NEW GLASS VIALS, AS OPPOSED TO GLASS AMPOULES.NEWLY MANUFACTURED SHIPMENT OF LIPIODOL IN NEW VIAL CONTAINER CLOSURE SYSTEM WILL BE DELIVERED TO CUSTOMERS DURING WEEK OF APRIL 1, 2019..  Full Article

Guerbet Says OptiVantage Multi-Use Injector Is Now CE-Marked
Friday, 23 Nov 2018 

Nov 23 (Reuters) - GUERBET SA ::OPTIVANTAGE MULTI-USE INJECTOR IS NOW CE-MARKED..OPTIVANTAGE®MULTI-USE WILL INITIALLY BE MARKETED IN EMEA FROM JANUARY 2019,.  Full Article

Guerbet 9-Month Revenue Down At 581.4 Million Euros
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - GUERBET SA ::OUTLOOK FOR 2018 REMAINS UNCHANGED.REPORTING REVENUE OF €581.4M FOR THE FIRST NINE MONTHS OF THE 2018 FINANCIAL YEAR, DOWN 3.3%.  Full Article

Guerbet Sees 2018 Sales Slightly Exceeding 2017 Sales
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - GUERBET SA ::H1 NET REVENUE EUR 389.6 MILLION VERSUS EUR 407.1 MILLION YEAR AGO.H1 EBITDA EUR 59.6 MILLION VERSUS EUR 64.5 MILLION YEAR AGO.H1 NET INCOME EUR 22.4 MILLION VERSUS EUR 23.1 MILLION YEAR AGO.SEES 2018 SALES SLIGHTLY EXCEEDING 2017 SALES AT CONSTANT EXCHANGE RATES.  Full Article

Guerbet H1 Net Income Down At 22.4 Million Euros
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - GUERBET SA ::H1 NET INCOME EUR 22.4 MILLION VERSUS EUR 23.1 MILLION YEAR AGO.H1 OPERATING INCOME EUR 36.6 MILLION VERSUS EUR 40.7 MILLION YEAR AGO.H1 REVENUE EUR 389.6 MILLION VERSUS EUR 407.1 MILLION YEAR AGO.FOR 2018, EXPECTS SALES TO BE SLIGHTLY HIGHER THAN IN 2017 AT CONSTANT EXCHANGE RATES.SEES FY RESTATED EBITDA AROUND 15% OF REVENUE.  Full Article

Guerbet H1 Revenue Down At 389.6 Million Euros
Thursday, 26 Jul 2018 

July 26 (Reuters) - GUERBET SA ::H1 REVENUE EUR 389.6 MILLION VERSUS EUR 407.1 MILLION PUBLISHED YEAR AGO.CONFIRMS OBJECTIVES FOR 2018.  Full Article

Guerbet Expects 2018 Revenue In-Line With 2017
Wednesday, 18 Apr 2018 

April 18 (Reuters) - Guerbet SA ::FOR 2018, EXPECTS REVENUE IN-LINE WITH 2017 AT CONSTANT EXCHANGE RATES.FOR 2018, EXPECTS EBITDA MARGIN DOWN BY C. 2 PERCENTAGE POINTS OF REVENUE COMPARED TO 2017.FOR 2020, AND TAKING INTO ACCOUNT INTERNAL BOOST INITIATIVES ONLY, TARGETS REVENUE BETWEEN €850M AND €900M AT CER.FOR 2020, AND TAKING INTO ACCOUNT INTERNAL BOOST INITIATIVES ONLY, TARGETS EBITDA MARGIN ABOVE 16.5%.FOR 2023 TARGETS REVENUE OF AROUND C. €1.0 BILLION AT CONSTANT EXCHANGE RATES AND AN EBITDA MARGIN ABOVE 20%.TARGETS NET CAPITAL EXPENDITURE OF C. €50M WITH ADDITIONAL ONE-OFF IMPACT OF C. €10M IN 2020 AND 2021.FOR 2023 TARGETS NET CAPITAL EXPENDITURE OF C. € 50 MILLION.TARGETS TO GENERATE €100M TO €150M OF REVENUE IN 2023 FROM COMPANIES ACQUIRED OVER 2018-2023 IN INTERVENTIONAL IMAGING.EXTERNAL BOOST INITIATIVES TO BE ACHIEVED OVER 2018-2023 ARE TARGETED TO CONTRIBUTE AN ADDITIONAL €150M TO €250M OF REVENUE BY 2023.GUERBET HAS IDENTIFIED PIPELINE OF REALISTIC TARGETS AND HAS AMBITION TO SIGN TWO ACQUISITIONS BEFORE END OF 2018.EXTERNAL BOOST INITIATIVES TO BE ACHIEVED OVER 2018-2023 ARE TARGETED TO HAVE AN OVERALL POSITIVE IMPACT ON EBITDA MARGIN.  Full Article

Guerbet Q1 Revenue Stable At 196.5 Million Euros
Wednesday, 18 Apr 2018 

April 18 (Reuters) - Guerbet SA ::Q1 REVENUE EUR 196.5 MILLION VERSUS EUR 197.3 MILLION YEAR AGO.FOR FY 2018 CONFIDENT IN FINANCIAL OBJECTIVES PRESENTED IN GEAR 2023 STRATEGIC PLAN.  Full Article

Guerbet Partners With Lausanne’S CHUV And CET To Launch Clinical Study
Friday, 13 Apr 2018 

April 13 (Reuters) - Guerbet SA ::PARTNERS WITH LAUSANNE’S CHUV AND CET TO LAUNCH A CLINICAL STUDY.PARTNERS TO WORK TO CLARIFY IMMUNOMODULATORY AND ACTIVATING MECHANISMS INDUCED BY A CTACE PROCEDURE IN 20 PATIENTS WITH HCC.  Full Article

French and Benelux stocks-Factors to watch

April 19 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.